top of page
The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in New York in 2022.
Economic
Output
$103B
Direct Jobs Supported by the Industry
71,598
Total Jobs Supported by the Industry
287,270
State Total Vendor Relationships
4,296
State Total Vendor Spending
$9,708,526,547
Clinical Trials
4,540
Clinical Trial Participants
2,410,394
bottom of page